Raphas Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Axis Investment Co., Ltd., Shinhan Investment Corp.
August 18, 2021
Share
Raphas Co., Ltd. announced that it will issue series 4 Unregistered nonguaranteed private convertible bonds for gross proceeds of KRW 30,000,000,000 on August 19, 2021. The bonds do not carry interest rate and will mature on August 23, 2026. The notes are 100% convertible into 587,325 shares at a price of KRW 51,079 from August 23, 2022 to July 23, 2026. The transaction has been approved by board of directors of the company. The securities issued will be subject to hold period of one year. The transaction is expected to close on August 23, 2021. The transaction will include participation from New Growth One New Technology Fund II, a fund managed by Axis Investment Co., Ltd. for KRW 4,000,000,000, Shinhan Investment Corp. for KRW 1,000,000,000, Platinum-Innovative Venture Fund for KRW 3,000,000,000
Raphas Co., Ltd. is a Korea-based company mainly engaged in the research, development manufacturing and distribution of microarray patches. The Company develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.